BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24469458)

  • 1. The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.
    Lavall D; Selzer C; Schuster P; Lenski M; Adam O; Schäfers HJ; Böhm M; Laufs U
    J Biol Chem; 2014 Mar; 289(10):6656-6668. PubMed ID: 24469458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling.
    Lavall D; Schuster P; Jacobs N; Kazakov A; Böhm M; Laufs U
    J Biol Chem; 2017 May; 292(18):7542-7553. PubMed ID: 28320863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling.
    Lavall D; Jacobs N; Mahfoud F; Kolkhof P; Böhm M; Laufs U
    Biochem Pharmacol; 2019 Oct; 168():173-183. PubMed ID: 31283930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.
    Adam O; Lavall D; Theobald K; Hohl M; Grube M; Ameling S; Sussman MA; Rosenkranz S; Kroemer HK; Schäfers HJ; Böhm M; Laufs U
    J Am Coll Cardiol; 2010 Feb; 55(5):469-80. PubMed ID: 20117462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
    Adam O; Zimmer C; Hanke N; Hartmann RW; Klemmer B; Böhm M; Laufs U
    J Mol Cell Cardiol; 2015 Aug; 85():140-50. PubMed ID: 26047574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes.
    Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP
    Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation.
    Adam O; Theobald K; Lavall D; Grube M; Kroemer HK; Ameling S; Schäfers HJ; Böhm M; Laufs U
    J Mol Cell Cardiol; 2011 Apr; 50(4):678-85. PubMed ID: 21215756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo.
    Messaoudi S; Gravez B; Tarjus A; Pelloux V; Ouvrard-Pascaud A; Delcayre C; Samuel J; Launay JM; Sierra-Ramos C; Alvarez de la Rosa D; Clément K; Farman N; Jaisser F
    Hypertension; 2013 Feb; 61(2):361-7. PubMed ID: 23297371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes.
    Tsai CF; Yang SF; Chu HJ; Ueng KC
    Int J Cardiol; 2013 Oct; 169(1):17-28. PubMed ID: 24120080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.
    Tsai CT; Chiang FT; Tseng CD; Hwang JJ; Kuo KT; Wu CK; Yu CC; Wang YC; Lai LP; Lin JL
    J Am Coll Cardiol; 2010 Feb; 55(8):758-70. PubMed ID: 20170814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats.
    Kimura S; Ito M; Tomita M; Hoyano M; Obata H; Ding L; Chinushi M; Hanawa H; Kodama M; Aizawa Y
    Hypertens Res; 2011 May; 34(5):584-91. PubMed ID: 21248754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation.
    De-An P; Li L; Zhi-Yun X; Jin-Yu H; Zheng-Ming X; Min W; Qiang Y; Shi-Eng H
    Clin Cardiol; 2010 Jan; 33(1):23-9. PubMed ID: 20063294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity.
    Brem AS; Morris DJ; Ge Y; Dworkin L; Tolbert E; Gong R
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1178-87. PubMed ID: 20200098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Aldosterone Receptor Antagonist Eplerenone Inhibits Isoproterenol-Induced Collagen-I and 11β-HSD1 Expression in Rat Cardiac Fibroblasts and the Left Ventricle.
    Hori Y; Touei D; Saitoh R; Yamagishi M; Kanai K; Hoshi F; Itoh N
    Biol Pharm Bull; 2017; 40(10):1716-1723. PubMed ID: 28966243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases].
    Pei DA; Li L; Xu ZY; Zou LJ; Zhang BR; Huang SD; Hao JH; Wang ZN; Lu FL
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):816-9. PubMed ID: 17565863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of miR-21 in the pathogenesis of atrial fibrosis.
    Adam O; Löhfelm B; Thum T; Gupta SK; Puhl SL; Schäfers HJ; Böhm M; Laufs U
    Basic Res Cardiol; 2012 Sep; 107(5):278. PubMed ID: 22760500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR‑132 in atrial fibrillation directly targets connective tissue growth factor.
    Qiao G; Xia D; Cheng Z; Zhang G
    Mol Med Rep; 2017 Oct; 16(4):4143-4150. PubMed ID: 28731126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Displacement of cortisol from human heart by acute administration of a mineralocorticoid receptor antagonist.
    Iqbal J; Andrew R; Cruden NL; Kenyon CJ; Hughes KA; Newby DE; Hadoke PW; Walker BR
    J Clin Endocrinol Metab; 2014 Mar; 99(3):915-22. PubMed ID: 24423282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.